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Background: A recently modified World Health Organization (WHO) Formulation I was examined as 80% and 97%
solutions against poliovirus type 1, adenovirus type 5 and murine norovirus according to the new European Norm
prEN 14476:2011. In a previous study the unmodified WHO Formulation I had failed to demonstrate a sufficient
activity against poliovirus type 1 according to the European Norm EN 14476–2007 whereas a sufficient activity was
seen with adeno- and norovirus.
Findings: The modified WHO Formulation I demonstrated a virucidal activity against all 3 test viruses of the
European Norm prEN 14476:2011 under clean conditions. This was achieved as 80% solution against adeno- and
norovirus within 30 seconds and as 97% solution against poliovirus within 60 seconds. Testing the unmodified
WHO Formulation I against poliovirus type 1 in the 97% assay of the European Norm prEN 14476:2011 an identical
activity could be demonstrated. When comparing the 80% and the 97% assay of the European Norm prEN
14476:2011 the modified WHO Formulation I as 80% solution was active against adenovirus type 5 within 30
seconds whereas the 97% solution failed within 2 minutes exposure time.
Conclusions: The technical possibility in the new European Norm prEN 14476:2011 allows testing a ready-to-use
disinfectant as 97% solution and is responsible for the new virucidal claim of the modified WHO Formulation I.
In contrast to the improvements with poliovirus type 1 the activity against adenovirus type 5 decreased when
increasing the test concentration from 80% to 97%.
Keywords: Alcohol-based handrubs, Hand antisepsis, Infection prevention and control, WHO Formulation I,
Virucidal activity, Quantitative suspension test, prEN 14476:2011Findings
In 2009, the World Health Organization (WHO) pub-
lished two alcohol-based Formulations to be used in
healthcare settings where commercial hand rubs are too
expensive or not available [1]. Later it was shown that
both Formulations were not able to fulfil the requirements
of the European Norm (EN) 12971 [2] for surgical hand
treatment [3]. In addition, both Formulations did not
meet the requirements for virucidal activity according
to EN 14476:2007–02 [4] with polio- and adenovirus* Correspondence: jochen-steinmann@t-online.de
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article, unless otherwise stated.[5]. Formulation I, based on 80% (vol/vol) ethanol,
demonstrated a much better activity than Formulation
II (based on 75% (vol/vol) isopropyl alcohol) against
the test viruses. But even Formulation I failed to
achieve a 4 log10 reduction of poliovirus titre [4].
Meanwhile, it was found that glycerol significantly
decreases the efficacy of alcohol-based surgical hand
rubs [6]. In order to reach an efficacy for the surgical
hand treatment, the WHO Formulations were proposed
to be modified with higher alcohol (mass instead of
volume percentage, now approximately 85% ethanol)
and lower glycerol concentration (0.725%) now fulfilling
the requirements of the EN 12791 [7]. In parallel testingtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
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In the prEN 14476:2011 [8] it is now allowed to examine
ready-to-use products as 97% solutions. Furthermore,
murine norovirus (MNV) is included as test virus as
surrogate for human norovirus. The soil load used was
0.03% bovine serum albumin (BSA) as final concentration.
A 4 log10 reduction of virus titre is still necessary to
demonstrate virucidal activity [8].
Following these recent developments the aim of the
present study was to examine the modified WHO
Formulation I against the test viruses mentioned in
the prEN 14476:2011. Can the modification of the
ingredients and/ or an increase of the test concentration
cause a complete virucidal activity which was missed in
our previous study [5]?
The prEN 14476:2011 [8] was chosen as a test method
evaluating the activity of the old and the modified WHO
Formulations I against the poliovirus type 1 strain LSc-2ab,
adenovirus type 5 strain Adenoid 75 and MNV strain S99.A
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Figure 1 Activity of the old (poliovirus only) and the proposed new W
(D) tested as 80% and 97% solutions under clean conditions. VirucidalPoliovirus was cultivated with buffalo green monkey
(BGM) cells, whereas A-549 cells (human lung carcinoma
cell line) were used for titration of adenovirus. MNV test
suspension and virus detection were prepared with RAW
264.7 cells (a macrophage-like, Abelson leukemia virus
transformed cell line derived from BALB/c mice). All tests
were conducted in accordance with the European Norm
in duplicates. Eight parts by volume of the Formulation
were mixed with one part by volume of the test virus
suspension and one part by volume of 0.3% BSA resulting
in an 80% concentration of the Formulation I. Testing
the 97% solution one part by volume of the test virus
suspension and the one part by volume of the interfering
substance (5x) were mixed with 9.7 parts by volume of
Formulation I. Activity was immediately stopped by serial
dilution with virus controls after the longest exposure
time. Infectivity was determined in a micro-procedure
by endpoint dilution titration (TCID50). Titre reduction
calculated as the difference between the virus titre ofB
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HO Formulation I against polio- (A, B), noro- (C) and adenovirus
activity is given as reduction factor wit 95% confidence interval.
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reduction factor (RF).
The modified WHO Formulation I when tested as 80%
solution was not active against poliovirus type 1 within
120 and 300 seconds exposure time (Figure 1A) despite
the increased ethanol content. But increasing the test
concentration to 97% an activity was found with the old
and the new Formulations within 60 seconds (Figure 1B).
Testing the modified WHO Formulation I against
MNV the 80% solution demonstrated virucidal activity
(RF ≥ 5.38) within 30 seconds (Figure 1C). This was already
previously shown with PBS as interfering substance (5).
After this exposure time a RF of ≥ 4.25 was determined
with the 97% solution (Figure 1C).
In addition, the modified WHO Formulation I was also
active against adenovirus type 5 as 80% solution within
30 seconds (RF ≥ 4.94). Increasing the concentration in
the test mixture to 97% no sufficient activity was found
after 120 seconds as the longest exposure time in the
prEN 14476:2011 (Figure 1D).
Nevertheless, in this study a sufficient activity of the
modified WHO Formulation I as 80% solution against
noro- and adenovirus and as 97% solution against
poliovirus was shown despite the change of the interfering
substance from PBS (EN 14476:2007) to clean conditions
(prEN 14476:2011). Due to the reduced amount of test
virus suspension (100 μl instead 1 ml) virus titres used
for the calculation of the RF in the 97% assay were
lower than in the 80% assay resulting consequently also in
lower RFs when testing an identical test virus suspension.
Despite the lowering of virus titre when examining 97%
solution a 4 log10 reduction can be detected with the
poliovirus within 60 seconds. Surprisingly, in the test
with the adenovirus type 5 the change from 80% to the
97% concentration is combined with a decrease of viral
activity. At the moment there is no clear explanation of
this phenomenon in the quantitative suspension test. In
addition, the practical consequences for hand hygiene also
remain obscure when an activity against adenovirus at
the human hands is required. There are no data available
concerning a reduced activity of ethanol against human
adenovirus at the human hands based on the established
test methods like the ASTM Standards E 2011 – 09 (using
the entire hands) and E 1838 – 10 (using the fingerpads)
when increasing the concentration of the active ingredient
[9,10]. In a previous study with feline calicivirus (FCV)
as former surrogate of norovirus it was seen that in the
suspension assay ethanol achieved a maximum of activity
at a concentration of 67% v/v and with the fingerpad
method 70% v/v ethanol was more active than 90% v/v
against FCV [11].
In summary, in the prEN 14474:2011 there is the new
possibility to test a ready-to-use disinfectant as 97%
solution when a sufficient activity is not available as 80%[8]. For claiming an activity against poliovirus not the
modified amount of ethanol and glycerol is responsible
for demonstration a RF of 4 log10 steps but exclusively
the increase of test concentration in the test mixture.
Therefore, after this technical change the modified WHO
Formulation I can be declared as virucidal in the quan-
titative suspension test strengthening the importance to
use this Formulation in hospitals where virus infections
often occur. Furthermore, testing with 97% is more
realistic than the 80% assay comparing with practical
use where handrubs are used undiluted. But the missing
activity against adenovirus type 5 for the 97% concentration
in the quantitative suspension assay within 2 minutes
exposure time and the impact of this finding on daily
practice has still to be clarified.
The quantitative suspension has still great limitations
when creating a virucidal claim of a handrub and making
use-recommendations. But a sufficient in vivo efficacy
of a handrub cannot be expected if no activity can be
found in the suspension test. Therefore, performing the
prEN 14476:2011 is still necessary before starting an
assay with artificially contaminated hands of volunteers.
After demonstrating the activity in the suspension test the
value of the modified WHO Formulation I to inactivate
chosen test viruses at the artificially contaminated hand
is still waiting.
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